SAB Biotherapeutics(SABS)
$2.95-0.05 (-1.67%)
SABS
SAB Biotherapeutics earnings date
$2.95
At close:-0.05 (-1.67%)
Want to see SABS full AI Analyst Report?
SAB Biotherapeutics (SABS) Q2 2023 Earnings Report
332 Followers
SABS Q2 2023 EPS Results
- Actual EPS
- -$1.40
- Consensus EPS
- -$1.40
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -$1.10
SABS Q2 2023 Revenue Results
- Actual Revenue
- $85.52K
- Expected Revenue
- $400.00K
- Beat/Miss
- Missed by -$314.48K
- YoY Revenue Growth
- -98.65%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/21/2023
- Time
- Before Open
- Conference Call
- Monday, August 21, 2023
SABS Upcoming Earnings
SAB Biotherapeutics's next earnings date is estimated for April 1, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
SABS Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 01, 2027 | 2026 (Q4) | -0.24- | -0.35 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.28-0.24 | -0.21 | -14.29% (-0.03) | |
| Aug 06, 2026 | 2026 (Q2) | -0.29-0.28 | -1.09 | 74.31% (+0.81) | |
| May 12, 2026 | 2026 (Q1) | -0.21-0.35 | -0.56 | 37.50% (+0.21) | |
| Mar 26, 2026 | 2025 (Q4) | -0.21-0.27 | -1.23 | 78.05% (+0.96) | |
| Nov 13, 2025 | 2025 (Q3) | -0.46-0.21 | -1.12 | 81.25% (+0.91) | |
| Aug 07, 2025 | 2025 (Q2) | -0.80-1.09 | -0.79 | -37.97% (-0.30) | |
| May 09, 2025 | 2025 (Q1) | ―- | -0.54 | ― | |
| Mar 31, 2025 | 2024 (Q4) | -1.07-0.56 | -0.54 | -3.70% (-0.02) | |
| Nov 06, 2024 | 2024 (Q3) | -1.11-1.12 | -1 | -12.00% (-0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

